Insufficient scRNA-seq data for expression of PVR at single-cell level.
Insufficient scRNA-seq data for expression of PVR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3974.85 | 226 / 226 | 100% | 29.86 | 405 / 406 |
uterus | 100% | 2003.04 | 170 / 170 | 100% | 28.26 | 457 / 459 |
kidney | 100% | 2676.12 | 89 / 89 | 100% | 23.79 | 897 / 901 |
pancreas | 100% | 1641.77 | 328 / 328 | 99% | 31.23 | 177 / 178 |
lung | 100% | 3908.91 | 578 / 578 | 99% | 28.83 | 1148 / 1155 |
prostate | 100% | 2316.68 | 244 / 245 | 100% | 26.01 | 501 / 502 |
intestine | 100% | 1796.64 | 966 / 966 | 99% | 37.85 | 522 / 527 |
stomach | 100% | 1891.80 | 359 / 359 | 99% | 41.08 | 283 / 286 |
esophagus | 100% | 1943.77 | 1445 / 1445 | 99% | 38.68 | 181 / 183 |
adrenal gland | 100% | 3419.38 | 258 / 258 | 98% | 29.85 | 225 / 230 |
bladder | 100% | 1895.76 | 21 / 21 | 97% | 27.61 | 489 / 504 |
skin | 100% | 2149.07 | 1805 / 1809 | 97% | 25.06 | 458 / 472 |
thymus | 100% | 2282.96 | 653 / 653 | 95% | 12.22 | 577 / 605 |
ovary | 100% | 2032.66 | 180 / 180 | 92% | 14.82 | 395 / 430 |
breast | 100% | 1732.43 | 459 / 459 | 92% | 14.40 | 1025 / 1118 |
brain | 95% | 1285.75 | 2517 / 2642 | 94% | 11.00 | 660 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.04 | 1 / 1 |
blood vessel | 100% | 2635.92 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1973.51 | 1203 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 985.83 | 240 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 1952.97 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2945.06 | 845 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 23.19 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 98% | 14.88 | 78 / 80 |
peripheral blood | 31% | 185.93 | 291 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.93 | 8 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060370 | Biological process | susceptibility to T cell mediated cytotoxicity |
GO_0002860 | Biological process | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0042271 | Biological process | susceptibility to natural killer cell mediated cytotoxicity |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007157 | Biological process | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0045954 | Biological process | positive regulation of natural killer cell mediated cytotoxicity |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0005912 | Cellular component | adherens junction |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0001618 | Molecular function | virus receptor activity |
Gene name | PVR |
Protein name | Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155) PVR cell adhesion molecule PVR cell adhesion molecule (Poliovirus receptor, isoform CRA_c) |
Synonyms | PVS hCG_1996181 |
Description | FUNCTION: Mediates NK cell adhesion and triggers NK cell effector functions. Binds two different NK cell receptors: CD96 and CD226. These interactions accumulates at the cell-cell contact site, leading to the formation of a mature immunological synapse between NK cell and target cell. This may trigger adhesion and secretion of lytic granules and IFN-gamma and activate cytotoxicity of activated NK cells. May also promote NK cell-target cell modular exchange, and PVR transfer to the NK cell. This transfer is more important in some tumor cells expressing a lot of PVR, and may trigger fratricide NK cell activation, providing tumors with a mechanism of immunoevasion. Plays a role in mediating tumor cell invasion and migration. .; FUNCTION: (Microbial infection) Acts as a receptor for poliovirus. May play a role in axonal transport of poliovirus, by targeting virion-PVR-containing endocytic vesicles to the microtubular network through interaction with DYNLT1. This interaction would drive the virus-containing vesicle to the axonal retrograde transport. .; FUNCTION: (Microbial infection) Acts as a receptor for Pseudorabies virus. .; FUNCTION: (Microbial infection) Is prevented to reach cell surface upon infection by Human cytomegalovirus /HHV-5, presumably to escape immune recognition of infected cell by NK cells. . |
Accessions | P15151 ENST00000706604.1 ENST00000706606.1 ENST00000403059.8 [P15151-2] ENST00000706607.1 A0A9L9PY64 A0A9L9PX39 K7EMC6 ENST00000406449.8 F8W7D4 A0A9L9PXN8 ENST00000706603.1 ENST00000344956.8 [P15151-3] A0A0C4DG49 ENST00000425690.8 ENST00000187830.2 A0A0A0MSA9 A0A9L9PXB8 ENST00000587785.1 |